"At Allergy Partners, we strive to be recognized as leaders in the development and delivery of high-quality health care for patients with asthma and allergic disease. Our vast care network of providers work together to promote education, research & innovation in the field of allergy & asthma care."

During the past decade, Allergy Partners of Western North Carolina conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy Partners of Western North Carolina" #1 sponsor was "Shire" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Regeneron Pharmaceuticals" with 2 trials sponsored, "Teva Branded Pharmaceutical Products R&D, Inc." with 2 trials sponsored and "ALK-Abelló A/S" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy Partners of Western North Carolina" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Allergy Partners of Western North Carolina" are "Asthma" (7 trials), "Hereditary Angioedema (HAE)" (3 trials), "Allergic Rhinitis Due to Cat Allergy" (1 trials), "Allergic Rhinitis Due to Dermatophagoides Farinae" (1 trials) and "Allergic Rhinitis Due to Dermatophagoides Pteronyssinus" (1 trials). Many other conditions were trialed in "Allergy Partners of Western North Carolina" in a lesser frequency.

Most popular intervention types in "Allergy Partners of Western North Carolina" are "Drug" (15 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ecallantide" (3 trials), "Omalizumab" (2 trials), "Budesonide/Formoterol fumarate dihydrate" (1 trials) and "DUPIXENT®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Partners of Western North Carolina" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Allergy Partners of Western North Carolina". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Allergy Partners of Western North Carolina, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Partners of Western North Carolina, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".